137 related articles for article (PubMed ID: 3133328)
1. Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancer.
Morton JD; Peschel RE
Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1153-7. PubMed ID: 3133328
[TBL] [Abstract][Full Text] [Related]
2. Iodine-125 implants for carcinoma of the prostate.
Peschel RE; Fogel TD; Kacinski BM; Kelly K; Mate TP
Int J Radiat Oncol Biol Phys; 1985 Oct; 11(10):1777-81. PubMed ID: 4044340
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy for prostate cancer. Long-term results and implications for future advances.
Ennis RD; Peschel RE
Cancer; 1993 Nov; 72(9):2644-50. PubMed ID: 8402485
[TBL] [Abstract][Full Text] [Related]
4. External beam irradiation versus 125 iodine implant in the definitive treatment of prostate carcinoma.
Koprowski CD; Berkenstock KG; Borofski AM; Ziegler JC; Lightfoot DA; Brady LW
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):955-60. PubMed ID: 1917625
[TBL] [Abstract][Full Text] [Related]
5. Prostatic cancer therapy: comparison of external-beam radiation and I-125 seed implantation treatment of stages B and C neoplasms.
Morton JD; Harrison LB; Peschel RE
Radiology; 1986 Apr; 159(1):249-52. PubMed ID: 3754056
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy.
Zagars GK; von Eschenbach AC; Ayala AG
Cancer; 1993 Sep; 72(5):1709-25. PubMed ID: 7688659
[TBL] [Abstract][Full Text] [Related]
7. Interstitial gold and external beam irradiation for prostate cancer.
Boileau MA; Dowling RA; Gonzales M; Handel PH; Benson GS; Corriere JN
J Urol; 1988 May; 139(5):985-8. PubMed ID: 3129584
[TBL] [Abstract][Full Text] [Related]
8. Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate.
Perez CA; Lee HK; Georgiou A; Logsdon MD; Lai PP; Lockett MA
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):581-91. PubMed ID: 8330986
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy.
Puthawala AA; Syed AM; Austin PA; Cherlow JM; Perley JM; Shanberg AM; Sawyer DE; Ingram JE; Baghdassarian R; Wachs BH; Perley JE; Londrc A; Espinoza-Ferrel T
Cancer; 2001 Oct; 92(8):2084-94. PubMed ID: 11596024
[TBL] [Abstract][Full Text] [Related]
10. Comparison of whole pelvis versus small-field radiation therapy for carcinoma of prostate.
Ploysongsang S; Aron BS; Shehata WM; Jazy FK; Scott RM; Ho PY; Morand TM
Urology; 1986 Jan; 27(1):10-6. PubMed ID: 3079933
[TBL] [Abstract][Full Text] [Related]
11. Radiation treatment of FIGO stage IVA carcinoma of the cervix.
Kramer C; Peschel RE; Goldberg N; Kohorn EI; Chambers JT; Chambers SK; Schwartz PE
Gynecol Oncol; 1989 Mar; 32(3):323-6. PubMed ID: 2920952
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for prostate carcinoma.
Leonard K; Stryker JA
J Surg Oncol; 1986 Sep; 33(1):1-7. PubMed ID: 3093775
[TBL] [Abstract][Full Text] [Related]
13. Treatment of clinical local failure after radiation therapy for prostate carcinoma.
Schellhammer PF; Kuban DA; el-Mahdi AM
J Urol; 1993 Dec; 150(6):1851-5. PubMed ID: 8230518
[TBL] [Abstract][Full Text] [Related]
14. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
Stromberg J; Martinez A; Benson R; Garton G; Diokno A; Gonzalez J; Zincke H; Schray M; Edmundson G; Brabbins D
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):67-75. PubMed ID: 8270460
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the prostate: radioactive gold seed implant plus external irradiation.
Gutierrez AE; Merino OR
Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1317-22. PubMed ID: 3143692
[TBL] [Abstract][Full Text] [Related]
16. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
Perez CA; Michalski J; Brown KC; Lockett MA
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
[TBL] [Abstract][Full Text] [Related]
17. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
[TBL] [Abstract][Full Text] [Related]
18. Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.
Merrick GS; Butler WM; Galbreath RW; Lief JH
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):41-8. PubMed ID: 11516849
[TBL] [Abstract][Full Text] [Related]
19. Iodine 125 seed implants for prostatic carcinoma. Five- and ten-year follow-up.
Weyrich TP; Kandzari SJ; Jain PR
Urology; 1993 Feb; 41(2):122-6. PubMed ID: 8497980
[TBL] [Abstract][Full Text] [Related]
20. High-dose radiotherapy for localized prostatic cancer. An analysis of treatment results and early complications.
Kearsley JH
Med J Aust; 1986 Jun; 144(12):624-8. PubMed ID: 3086680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
